Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Mar;19(3):928–933. doi: 10.1128/iai.19.3.928-933.1978

Antibody-Dependent Cytotoxicity Against Trypanosoma rhodesiense Mediated Through an Alternative Complement Pathway

Barbara Flemmings 1, Carter Diggs 1
PMCID: PMC422281  PMID: 417033

Abstract

A quantitative in vitro method was used to examine the role of classical and alternative pathways of complement activation in cytotoxicity against African trypanosomes by immune serum. This assay is based on the estimation of the extent of antibody-mediated cytotoxicity by measurement of inhibition of incorporation of [3H]leucine as an indicator of trypanosome metabolic integrity. To determine which pathway(s) is activated during cytotoxic events, complements sufficient in all components (C4S) and deficient in C4 (C4D) were used. Immune inhibition of [3H]leucine uptake by trypanosomes was observed in the presence of both complement sources. Treatment of C4S or C4D serum with cobra venom factor or disodium ethylenediaminetetraacetic acid abolished antibody-mediated cytotoxicity as well as immune hemolysis, thus suggesting the requirement for late-acting complement components. Ethyleneglycol-bis(β-aminoethyl ether)-N,N-tetraacetic acid had no effect on inhibition of leucine incorporation, whereas immune hemolysis was inhibited, suggesting that cytotoxicity did not require C1 activation, a Ca2+-dependent event. The dependence of the cytotoxic process on Mg2+ and not Ca2+ ions and the fact that C4D guinea pig serum is fully active in trypanosome cytotoxicity indicate that an alternative pathway of complement activation is sufficient for activity.

Full text

PDF
928

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Budzko D. B., Pizzimenti M. C., Kierszenbaum F. Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi. Infect Immun. 1975 Jan;11(1):86–91. doi: 10.1128/iai.11.1.86-91.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Diggs C., Flemmings B., Dillon J., Snodgrass R., Campbell G., Esser K. Immune serum-mediated cytotoxicity against Trypanosoma rhodesiense. J Immunol. 1976 Apr;116(4):1005–1009. [PubMed] [Google Scholar]
  3. Ellman L., Green I., Frank M. Genetically controlled total deficiency of the fourth component of complement in the guinea pig. Science. 1970 Oct 2;170(3953):74–75. doi: 10.1126/science.170.3953.74. [DOI] [PubMed] [Google Scholar]
  4. Fine D. P., Marney S. R., Jr, Colley D. G., Sergent J. S., Des Prez R. M. C3 shunt activation in human serum chelated with EGTA. J Immunol. 1972 Oct;109(4):807–809. [PubMed] [Google Scholar]
  5. Gaither T. A., Alling D. W., Frank M. M. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol. 1974 Aug;113(2):574–583. [PubMed] [Google Scholar]
  6. Greenwood B. M., Whittle H. C. Complement activation in patients with Gambian sleeping sickness. Clin Exp Immunol. 1976 Apr;24(1):133–138. [PMC free article] [PubMed] [Google Scholar]
  7. Hicks J. T., Klutch M. J., Albrecht P., Frank M. M. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles. J Immunol. 1976 Jul;117(1):208–215. [PubMed] [Google Scholar]
  8. Joseph B. S., Cooper N. R., Oldstone M. B. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway. J Exp Med. 1975 Apr 1;141(4):761–774. [PMC free article] [PubMed] [Google Scholar]
  9. Lachmann P. J., Nicol P. Reaction mechanism of the alternative pathway of complement fixation. Lancet. 1973 Mar 3;1(7801):465–467. doi: 10.1016/s0140-6736(73)91886-2. [DOI] [PubMed] [Google Scholar]
  10. Matossian-Rogers A., Lumsden W. H., Dumonde D. C. Numerical immunotaxonomy of Leishmania. I. Differentiation of four strains of Leishmania by serological tests. Immunology. 1976 Jul;31(1):1–19. [PMC free article] [PubMed] [Google Scholar]
  11. Nogueira N., Bianco C., Cohn Z. Studies on the selective lysis and purification of Trypanosoma cruzi. J Exp Med. 1975 Jul 1;142(1):224–229. doi: 10.1084/jem.142.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Perrin L. H., Joseph B. S., Cooper N. R., Oldstone M. B. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway. J Exp Med. 1976 May 1;143(5):1027–1041. doi: 10.1084/jem.143.5.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rane L., Rane D. S., Kinnamon K. E. Screening large numbers of compounds in a model based on mortality of Trypanosoma rhodesiense infected mice. Am J Trop Med Hyg. 1976 May;25(3):395–400. doi: 10.4269/ajtmh.1976.25.395. [DOI] [PubMed] [Google Scholar]
  14. Sandberg A. L., Osler A. G., Shin H. S., Oliveira B. The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins. J Immunol. 1970 Feb;104(2):329–334. [PubMed] [Google Scholar]
  15. Siroták L., Inoue K., Okada M., Amano T. Immune bactericidal reactions by guinea-pig gamma1 and gamma2 antibodies. Immunology. 1976 Mar;30(3):435–441. [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES